Annual Drug Patent Expiration for NEUPRO
Neupro is a drug marketed by Ucb Inc and included in one NDA. It is available from a single supplier. There are six patents protecting this drug and one Paragraph IV challenge.
NEUPRO drug price trends.
Drug patent litigation for NEUPRO.
This drug has seventy-four patent family members in twenty-nine countries.
The generic ingredient in NEUPRO is rotigotin. One registered supplier for this compound. Additional details are available on the rotigotine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in